Immuron Ltd(IMRN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IMRN Immuron Ltd

已收盘 11-26 16:00:00 EST

1.91

+0.03

+1.33%

盘后1.90

-0.01-0.26%

16:00 EST

最高1.95	最低1.86	成交量3,365
今开1.86	昨收1.88	日振幅4.79%
总市值1,091万	流通市值934.01万	总股本572.86万
成交额6,350	换手率0.07%	流通股本490.29万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"IMRN","market":"US","secType":"STK","nameCN":"Immuron Ltd","latestPrice":1.905,"timestamp":1732654800000,"preClose":1.88,"halted":0,"volume":3365,"hourTrading":{"tag":"盘后","latestPrice":1.9,"preClose":1.905,"latestTime":"16:00 EST","volume":5,"amount":9.5,"timestamp":1732654801978},"delay":0,"floatShares":4902946,"shares":5728635,"eps":-0.812463,"marketStatus":"已收盘","marketStatusCode":5,"change":0.025,"latestTime":"11-26 16:00:00 EST","open":1.855,"high":1.945,"low":1.855,"amount":6349.901378,"amplitude":0.047872,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.812463,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732698000000},"adr":1,"adjPreClose":1.88,"adrRate":40,"postHourTrading":{"tag":"盘后","latestPrice":1.9,"preClose":1.905,"latestTime":"16:00 EST","volume":5,"amount":9.5,"timestamp":1732654801978},"volumeRatio":0.843951},"requestUrl":"/m/hq/s/IMRN/tweets","defaultTab":"tweets","newsList":[{"id":"2485726164","title":"Immuron Limited盘中异动 快速跳水5.71%报1.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485726164","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485726164?lang=zh_cn&edition=full","pubTime":"2024-11-22 22:32","pubTimestamp":1732285937,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日22时32分，Immuron Limited股票出现波动，股价急速跳水5.71%。截至发稿，该股报1.80美元/股，成交量1476股，换手率0.03%，振幅3.22%。Immuron Limited股票所在的生物技术行业中，整体涨幅为0.29%。Immuron Limited公司简介：Immuron Ltd 是一家商业和临床阶段的生物制药公司，专注于开发和商业化一类新型免疫调节剂多克隆抗体，用于治疗肝病、传染病和其他免疫介导疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122223217abd7925b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122223217abd7925b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRN","BK4007","BK4139","VRPX"],"gpt_icon":0},{"id":"2484717949","title":"Immuron Limited盘中异动 股价大涨5.98%报1.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484717949","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484717949?lang=zh_cn&edition=full","pubTime":"2024-11-20 02:49","pubTimestamp":1732042160,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日02时49分，Immuron Limited股票出现异动，股价急速上涨5.98%。截至发稿，该股报1.95美元/股，成交量638股，换手率0.01%，振幅0.00%。Immuron Limited股票所在的生物技术行业中，整体跌幅为1.39%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112002492098e43922&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112002492098e43922&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRN","BK4139"],"gpt_icon":0},{"id":"2484761036","title":"Immuron Limited盘中异动 早盘大幅拉升10.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484761036","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484761036?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:33","pubTimestamp":1731940385,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时33分，Immuron Limited股票出现波动，股价大幅拉升10.50%。截至发稿，该股报2.00美元/股，成交量525股，换手率0.01%，振幅0.00%。Immuron Limited股票所在的生物技术行业中，整体跌幅为0.15%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822330595be4885&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822330595be4885&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRN"],"gpt_icon":0},{"id":"2483849301","title":"Immuron Limited盘中异动 大幅下跌6.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483849301","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483849301?lang=zh_cn&edition=full","pubTime":"2024-11-16 00:23","pubTimestamp":1731687785,"startTime":"0","endTime":"0","summary":"北京时间2024年11月16日00时23分，Immuron Limited股票出现波动，股价急速下跌6.22%。截至发稿，该股报1.81美元/股，成交量1543股，换手率0.03%，振幅5.44%。Immuron Limited股票所在的生物技术行业中，整体跌幅为3.49%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116002306971a6e9d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116002306971a6e9d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRN"],"gpt_icon":0},{"id":"2483881703","title":"Immuron Limited盘中异动 早盘急速跳水5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483881703","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483881703?lang=zh_cn&edition=full","pubTime":"2024-11-14 23:20","pubTimestamp":1731597650,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日23时20分，Immuron Limited股票出现波动，股价大幅跳水5.56%。截至发稿，该股报1.87美元/股，成交量406股，换手率0.01%，振幅0.51%。Immuron Limited股票所在的生物技术行业中，整体跌幅为0.88%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114232050a237ed51&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114232050a237ed51&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PULM","BK4007","BK4139","IMRN"],"gpt_icon":0},{"id":"2483858056","title":"Immuron Limited盘中异动 下午盘股价大跌5.76%报1.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483858056","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483858056?lang=zh_cn&edition=full","pubTime":"2024-11-14 02:14","pubTimestamp":1731521641,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日02时14分，Immuron Limited股票出现异动，股价大幅跳水5.76%。截至发稿，该股报1.73美元/股，成交量192股，换手率0.00%，振幅0.00%。Immuron Limited股票所在的生物技术行业中，整体跌幅为0.28%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111402140195be256f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111402140195be256f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRN"],"gpt_icon":0},{"id":"2481558400","title":"Immuron Limited盘中异动 下午盘股价大涨7.59%报2.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481558400","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481558400?lang=zh_cn&edition=full","pubTime":"2024-11-05 02:42","pubTimestamp":1730745736,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日02时42分，Immuron Limited股票出现波动，股价快速上涨7.59%。截至发稿，该股报2.10美元/股，成交量1255股，换手率0.02%，振幅2.16%。Immuron Limited股票所在的生物技术行业中，整体跌幅为0.13%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110502421698e40568&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110502421698e40568&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRN"],"gpt_icon":0},{"id":"2480887454","title":"Immuron Limited盘中异动 股价大涨6.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480887454","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480887454?lang=zh_cn&edition=full","pubTime":"2024-11-01 22:40","pubTimestamp":1730472011,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日22时40分，Immuron Limited股票出现异动，股价快速拉升6.77%。截至发稿，该股报2.05美元/股，成交量9023股，换手率0.16%，振幅3.13%。Immuron Limited股票所在的生物技术行业中，整体涨幅为0.47%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110122401198e40087&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110122401198e40087&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRN"],"gpt_icon":0},{"id":"2477919866","title":"Immuron Limited盘中异动 早盘股价大涨6.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477919866","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477919866?lang=zh_cn&edition=full","pubTime":"2024-10-21 21:52","pubTimestamp":1729518775,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日21时52分，Immuron Limited股票出现波动，股价急速上涨6.49%。截至发稿，该股报2.03美元/股，成交量115股，换手率0.00%，振幅0.00%。Immuron Limited股票所在的生物技术行业中，整体跌幅为0.53%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102121525598e3d890&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102121525598e3d890&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRN"],"gpt_icon":0},{"id":"2475906919","title":"Immuron Limited盘中异动 早盘股价大涨6.95%报2.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475906919","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475906919?lang=zh_cn&edition=full","pubTime":"2024-10-16 21:32","pubTimestamp":1729085555,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日21时32分，Immuron Limited股票出现波动，股价快速拉升6.95%。截至发稿，该股报2.00美元/股，成交量2035股，换手率0.04%，振幅0.00%。Immuron Limited股票所在的生物技术行业中，整体跌幅为0.28%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101621323595ad0c54&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101621323595ad0c54&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRN"],"gpt_icon":0},{"id":"2475638241","title":"Immuron Limited盘中异动 早盘大幅下跌5.85%报2.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475638241","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475638241?lang=zh_cn&edition=full","pubTime":"2024-10-15 22:59","pubTimestamp":1729004397,"startTime":"0","endTime":"0","summary":"北京时间2024年10月15日22时59分，Immuron Limited股票出现异动，股价急速下跌5.85%。截至发稿，该股报2.09美元/股，成交量2087股，换手率0.04%，振幅1.35%。Immuron Limited股票所在的生物技术行业中，整体跌幅为0.58%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241015225957a1e0d9e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241015225957a1e0d9e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRN","BK4139"],"gpt_icon":0},{"id":"2475367659","title":"Immuron Limited盘中异动 早盘股价大跌8.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475367659","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475367659?lang=zh_cn&edition=full","pubTime":"2024-10-14 21:31","pubTimestamp":1728912712,"startTime":"0","endTime":"0","summary":"北京时间2024年10月14日21时31分，Immuron Limited股票出现波动，股价快速下跌8.18%。截至发稿，该股报2.02美元/股，成交量813股，换手率0.01%，振幅0.00%。Immuron Limited股票所在的生物技术行业中，整体涨幅为0.08%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410142131529f41ca7a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410142131529f41ca7a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRN"],"gpt_icon":0},{"id":"2474946090","title":"Immuron Limited盘中异动 早盘快速拉升9.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474946090","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474946090?lang=zh_cn&edition=full","pubTime":"2024-10-11 21:32","pubTimestamp":1728653520,"startTime":"0","endTime":"0","summary":"北京时间2024年10月11日21时32分，Immuron Limited股票出现波动，股价大幅上涨9.87%。截至发稿，该股报2.45美元/股，成交量288股，换手率0.01%，振幅0.00%。Immuron Limited股票所在的生物技术行业中，整体涨幅为0.59%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410112132009f3aa4bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410112132009f3aa4bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRN"],"gpt_icon":0},{"id":"2474372533","title":"Immuron Limited股价飙升13.80% 市值涨197.66万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474372533","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474372533?lang=zh_cn&edition=full","pubTime":"2024-10-10 23:42","pubTimestamp":1728574943,"startTime":"0","endTime":"0","summary":"北京时间2024年10月10日23时42分，Immuron Limited股票出现异动，股价大幅上涨13.80%。截至发稿，该股报2.52美元/股，成交量168股，换手率0.00%，振幅0.00%。Immuron Limited股票所在的生物技术行业中，整体涨幅为0.37%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410102342249719f8d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410102342249719f8d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRN"],"gpt_icon":0},{"id":"2474054954","title":"Immuron Limited盘中异动 下午盘股价大涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474054954","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474054954?lang=zh_cn&edition=full","pubTime":"2024-10-09 01:08","pubTimestamp":1728407300,"startTime":"0","endTime":"0","summary":"北京时间2024年10月09日01时08分，Immuron Limited股票出现波动，股价急速上涨5.10%。截至发稿，该股报2.44美元/股，成交量1236股，换手率0.02%，振幅6.68%。Immuron Limited股票所在的生物技术行业中，整体涨幅为0.03%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410090108209719f049&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410090108209719f049&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRN"],"gpt_icon":0},{"id":"2473058091","title":"Immuron Limited盘中异动 大幅下跌5.95%报2.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473058091","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473058091?lang=zh_cn&edition=full","pubTime":"2024-10-07 21:33","pubTimestamp":1728308000,"startTime":"0","endTime":"0","summary":"北京时间2024年10月07日21时33分，Immuron Limited股票出现异动，股价急速跳水5.95%。截至发稿，该股报2.53美元/股，成交量236股，换手率0.00%，振幅0.00%。Immuron Limited股票所在的生物技术行业中，整体涨幅为0.16%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241007213320ab681a7b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241007213320ab681a7b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRN"],"gpt_icon":0},{"id":"2472796349","title":"Immuron Limited盘中异动 股价大跌5.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472796349","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472796349?lang=zh_cn&edition=full","pubTime":"2024-10-04 22:33","pubTimestamp":1728052400,"startTime":"0","endTime":"0","summary":"北京时间2024年10月04日22时33分，Immuron Limited股票出现异动，股价大幅下挫5.40%。截至发稿，该股报2.59美元/股，成交量3360股，换手率0.06%，振幅2.92%。Immuron Limited股票所在的生物技术行业中，整体跌幅为0.25%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241004223320ab67be5d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241004223320ab67be5d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRN"],"gpt_icon":0},{"id":"2470273475","title":"Immuron Limited盘中异动 早盘快速下跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470273475","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470273475?lang=zh_cn&edition=full","pubTime":"2024-09-26 21:32","pubTimestamp":1727357555,"startTime":"0","endTime":"0","summary":"北京时间2024年09月26日21时32分，Immuron Limited股票出现波动，股价快速下跌5.17%。截至发稿，该股报2.66美元/股，成交量2760股，换手率0.05%，振幅0.00%。Immuron Limited股票所在的生物技术行业中，整体涨幅为0.39%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240926213235957f799b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240926213235957f799b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRN","BK4139","KTTA"],"gpt_icon":0},{"id":"2469494942","title":"Immuron Limited盘中异动 股价大涨12.73%报2.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469494942","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469494942?lang=zh_cn&edition=full","pubTime":"2024-09-24 21:31","pubTimestamp":1727184683,"startTime":"0","endTime":"0","summary":"北京时间2024年09月24日21时31分，Immuron Limited股票出现异动，股价大幅拉升12.73%。截至发稿，该股报2.79美元/股，成交量2000股，换手率0.04%，振幅0.00%。Immuron Limited股票所在的生物技术行业中，整体跌幅为0.34%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409242131239f132330&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409242131239f132330&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRN","BK4139"],"gpt_icon":0},{"id":"2469485261","title":"Immuron Limited盘中异动 早盘股价大涨6.18%报2.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469485261","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469485261?lang=zh_cn&edition=full","pubTime":"2024-09-23 22:22","pubTimestamp":1727101378,"startTime":"0","endTime":"0","summary":"北京时间2024年09月23日22时22分，Immuron Limited股票出现波动，股价快速上涨6.18%。截至发稿，该股报2.67美元/股，成交量792股，换手率0.01%，振幅0.00%。Immuron Limited股票所在的生物技术行业中，整体跌幅为0.55%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240923222258a1dbeed5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240923222258a1dbeed5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRN","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.immuron.com","stockEarnings":[{"period":"1week","weight":0.0217},{"period":"1month","weight":-0.0319},{"period":"3month","weight":-0.2906},{"period":"6month","weight":-0.1966},{"period":"1year","weight":0.0162},{"period":"ytd","weight":0.0027}],"compareEarnings":[{"period":"1week","weight":0.0159},{"period":"1month","weight":0.0319},{"period":"3month","weight":0.0641},{"period":"6month","weight":0.1358},{"period":"1year","weight":0.3124},{"period":"ytd","weight":0.2571}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Immuron Limited于1994年根据澳大利亚法律成立。该公司是一家商业和临床阶段的生物制药公司，拥有一个专利技术平台，专注于开发和商业化一类新型的特异性靶向多克隆抗体，公司相信这种抗体能够解决严重的未满足医疗需求。","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":0.236802},{"month":2,"riseRate":0.142857,"avgChangeRate":-0.076928},{"month":3,"riseRate":0.428571,"avgChangeRate":0.034557},{"month":4,"riseRate":0.285714,"avgChangeRate":-0.002953},{"month":5,"riseRate":0.142857,"avgChangeRate":-0.10596},{"month":6,"riseRate":0.5,"avgChangeRate":0.38465},{"month":7,"riseRate":0.571429,"avgChangeRate":0.032443},{"month":8,"riseRate":0.571429,"avgChangeRate":-0.018746},{"month":9,"riseRate":0.375,"avgChangeRate":-0.070912},{"month":10,"riseRate":0.125,"avgChangeRate":-0.095831},{"month":11,"riseRate":0.5,"avgChangeRate":0.035563},{"month":12,"riseRate":0.142857,"avgChangeRate":-0.090493}],"exchange":"NASDAQ","name":"Immuron Ltd","nameEN":"Immuron Ltd"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Immuron Ltd(IMRN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Immuron Ltd(IMRN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Immuron Ltd,IMRN,Immuron Ltd股票,Immuron Ltd股票老虎,Immuron Ltd股票老虎国际,Immuron Ltd行情,Immuron Ltd股票行情,Immuron Ltd股价,Immuron Ltd股市,Immuron Ltd股票价格,Immuron Ltd股票交易,Immuron Ltd股票购买,Immuron Ltd股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Immuron Ltd(IMRN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Immuron Ltd(IMRN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}